EpimAb Biotherapeutics Announces FDA Clearance of its IND Application for EMB-02, a Bispecific Dual Checkpoint Inhibitor
IND filing of second bispecific antibody candidate developed from EpimAb’s FIT-Ig® platform SHANGHAI--(BUSINESS WIRE)--EpimAb Biotherapeutics,…